Document Detail

Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease.
MedLine Citation:
PMID:  15589008     Owner:  NLM     Status:  MEDLINE    
Chronotropic response is important during exercise stress testing. Less is known about its role after dobutamine stress echocardiography. In addition, limited information exists regarding the long-term prognostic value of dobutamine stress echocardiography in patients who have peripheral arterial disease. We studied 2,138 patients who had peripheral arterial disease (1,317 men, 70 +/- 10 years old) and who underwent dobutamine stress echocardiography. Follow-up was completed for all-cause mortality and cardiovascular morbidity (nonfatal myocardial infarction and coronary revascularization). Death and cardiovascular morbidity occurred in 961 patients (45%) and 348 patients (16%), respectively, during a follow-up of 6.1 +/- 2.7 years. Failure to achieve 85% of age-predicted maximal heart rate (hazard ratio [HR] 1.34, 95% confidence interval [CI] 1.16 to 1.54, p = 0.0001) and percent of abnormal segments at peak stress (HR/10% increment 1.04, 95% CI 1.01 to 1.07, p = 0.02) were independent predictors of mortality and morbidity (HR 1.35, 95% CI 1.06 to 1.71, p = 0.01 and HR 1.14, 95% CI 1.08 to 1.20, p <0.0001, respectively). The effect of not achieving the target heart rate during normal dobutamine stress echocardiography on 1-, 3-, 5-, and 10-year survival probabilities was comparable to that of ischemia (86% vs 88%, 75% vs 71%, 62% vs 59%, and 33% vs 32%, respectively; p = 0.8). In a stepwise multivariate model, dobutamine stress echocardiography had incremental value over clinical data and echocardiographic data at rest for predicting rates of mortality (model chi-square increase from 301 to 322, p <0.0001) and morbidity (model chi-square increase from 37 to 118, p <0.0001). In conclusion, chronotropic response and extent of abnormal segments at peak dobutamine stress provide incremental prognostic information in patients who have peripheral arterial disease.
Nithima Chaowalit; Joseph F Maalouf; Thom W Rooke; Marion E Barnes; Kent R Bailey; Patricia A Pellikka
Related Documents :
8025988 - Magnetic resonance imaging during dobutamine stress for detection and localization of c...
7594028 - Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to...
1396808 - Pharmacological stress echocardiography in the diagnosis of coronary artery disease and...
12883318 - Hemodynamic effects of a new inotropic compound, pst-2744, in dogs with chronic ischemi...
19043388 - Factors influencing restenosis after carotid artery stenting.
10406068 - Experiences with primary angioplasty without on site-cardiac surgery.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  94     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-13     Completed Date:  2005-01-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1523-8     Citation Subset:  AIM; IM    
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arterial Occlusive Diseases / mortality*,  physiopathology,  ultrasonography
Dobutamine / diagnostic use*
Echocardiography, Stress / methods*
Follow-Up Studies
Heart Rate / physiology*
Multivariate Analysis
Treatment Outcome
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postp...
Next Document:  Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction s...